This powerful, targeted anti-ageing serum addresses adult acne and signs of ageing with the unique technology of dioic acid, salicylic acid, LHA, glycolic acid, and citric acid to fight the formation of acne and reduce excess sebum production as it helps improve the appearance of fine lines, wrinkles, and rough surface texture that can lead to an aged appearance. Blemish + AGE Defence was shown to be as effective as the leading prescription drug combination, 1% clindamycin and 5% benzoyl peroxide, for the treatment of acne.
Clinical results were seen as early as day 2, with Blemish + AGE Defence significantly reducing inflammatory and non-inflammatory lesions.
Additionally, Blemish + AGE Defence also reduced blotchiness and clogged pores for the entire duration of the 8 week study. (Baumann, L. Comparison of clindamycin 1% and benzoyl peroxide 5% gel to a novel composition containing salicylic acid, capryloyl salicylic acid, HEPES, glycolic acid, citric acid, and dioic acid in the treatment of acne vulgaris - JDD - 2O13).
Blemish + AGE Defence was proven as effective and tolerable as 0.025% tretinoin in both anti-ageing and anti-acne attributes - B+AGE produced statistically superior improvements in skin tone, evenness and clarity, and a reduction in blemishes and blotchiness.
As early as day 2, B+AGE provided improvements in skin tone evenness and clarity, skin smoothness, skin brightness, clogged pores, blemishes, and blotchiness. Parity was achieved between the two treatments in reduction of fine lines, clogged pores, tactile roughness, and dullness.
At no point during the 8-week study did 0.025% tretinoin statistically outperform B+AGE. (Kircik, L. Safety and efficacy of two anti-acne/anti-ageing treatments in subjects with photodamaged skin and mild to moderate acne vulgaris - JDD - 2012).
After 4 weeks, Blemish + AGE Defence was proven to statistically reduce the grade of PIH by 19%.
After 8 weeks, it was proven to reduce the grade of PIH by 36% and the number of PIH marks by 29%.
(Protocol: 8-week dermatologist controlled study consisted of 59 subjects. The subject group consisted of males and females of multi-ethnicities, between the ages of 18-40 with skin types II-V that included mild acne and combination to oily skins, with at least 50% experiencing post-inflammatory hyperpigmentation).